Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 3/20 | 0.49 |
| ▸ | MMP2 | P08253 | 2/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | MMP8 | P22894 | 2/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 3/20 | 0.46 |
| ▸ | CCR3 | P51677 | 4/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGAV | P06756 | 1/20 | 0.43 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6807324 | 1.00 | TYMS (0.53) | TYMSNPY5RMMP1MMP2MMP9 | |
| SCHEMBL6801914 | 0.83 | NPY5R (0.52) | NPY5RMMP1MMP2MMP9MMP8 | |
| SCHEMBL6801908 | 0.83 | NPY5R (0.52) | NPY5RMMP1MMP2MMP9MMP8 | |
| SCHEMBL6799543 | 0.83 | MMP2 (0.55) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6799552 | 0.83 | MMP2 (0.55) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL3090740 | 0.79 | MMP1 (0.53) | TYMSMMP1MMP2MMP9MMP8 | |
| SCHEMBL6802343 | 0.78 | TDP1 (0.56) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6802333 | 0.78 | TDP1 (0.56) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL3096614 | 0.77 | MMP8 (0.48) | TYMSMMP1MMP2MMP9MMP8 | |
| SCHEMBL6912842 | 0.76 | POLB (0.56) | MMP1MMP2MMP9MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | TYMS 1731/4885NPY5R 1824/4885MMP1 857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.